Research Article

Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes

Volume: 9 Number: 1 January 5, 2026
EN TR

Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes

Abstract

Aims: This study aimed to investigate the prognostic value of C-reactive protein/albumin ratio (CAR), Fibrosis-4 (FIB-4) Index, procalcitonin, and hemoglobin, in conjunction with clinical severity scores, for predicting 28-day mortality and 90-day functional outcomes in patients with SDH. Methods: We conducted a retrospective cohort study including 118 adult SDH patients admitted to the intensive care unit of a tertiary university hospital between February 2021 and January 2025. Laboratory parameters (CRP, albumin, procalcitonin, CAR, FIB-4, NLR, PLR, and others) and clinical severity scores (GCS, APACHE II, SOFA) were recorded within the first 24 hours of admission. Primary outcomes were 28-day mortality and 90-day functional status assessed with the modified rankin scale (mRS), dichotomized as favorable (0-2) or poor (≥3). Results: The 28-day mortality rate was 19.5%, and poor 90-day functional outcome was observed in 54.2% of patients. Advanced age, elevated CAR, FIB-4, and procalcitonin levels, along with low albumin and hemoglobin levels, were significantly associated with poor outcomes (all p<0.05). Logistic regression identified age (OR=1.04, p=0.017), procalcitonin (OR=3.99, p=0.010), and hemoglobin (OR=0.73, p=0.013) as independent predictors of 28-day mortality. For 90-day outcomes, age (OR=1.06, p<0.001), albumin (OR=0.84, p<0.001), CRP (OR=1.02, p=0.001), and hemoglobin (OR=0.75, p=0.004) emerged as significant predictors. NLR and PLR were not prognostic. Conclusion: Early measurement of CAR, FIB-4, procalcitonin, and hemoglobin provides clinically meaningful prognostic value for both short-term mortality and long-term functional outcomes in SDH patients. Integrating these biomarkers with clinical scoring systems may enhance individualized risk stratification and guide early management strategies.

Keywords

Supporting Institution

Giresun University School of Medicine

Ethical Statement

The study protocol was approved by the Giresun Training and Research Hospital Ethics Committee (Date:25.06.2025, Decision No: 25.06.2025/18).

References

  1. Miller JD, Nader R. Acute subdural hematoma from bridging vein rupture: a potential mechanism for growth. J Neurosurg. 2014;120(6):13 78-1384. doi:10.3171/2013.10.JNS13272
  2. Fountain DM, Kolias AG, Lecky FE, et al. Survival Trends after surgery for acute subdural hematoma in adults over a 20-year period. Ann Surg. 2017;265(3):590-596. doi:10.1097/SLA.0000000000001682
  3. Azab B, Shah N, Akerman M, McGinn JT Jr. Value of platelet/lymphocyte ratio as a predictor of all-cause mortality after non-ST-elevation myocardial infarction. J Thromb Thrombolysis. 2012;34(3):326-334. doi:10.1007/s11239-012-0718-6
  4. Li W, Hou M, Ding Z, Liu X, Shao Y, Li X. Prognostic value of neutrophil-to-lymphocyte ratio in stroke: a systematic review and meta-analysis. Front Neurol. 2021;12:686983. doi:10.3389/fneur.2021.686983
  5. Tian R, Liu W, Dong J, et al. Prognostic predictors of early outcomes and discharge status of patients undergoing decompressive craniectomy after severe traumatic brain injury. World Neurosurg. 2019;126:e101-e108. doi:10.1016/j.wneu.2019.01.246
  6. Farah R, Samra N. Mean platelets volume and neutrophil to lymphocyte ratio as predictors of stroke. J Clin Lab Anal. 2018;32(1):e22189. doi:10.10 02/jcla.22189
  7. Gürsoy C, Gürsoy G, Demirbilek SG. C-reactive protein-albumin ratio and procalcitonin in predicting intensive care unit mortality in traumatic brain injury. Acute Crit Care. 2022;37(3):462-467. doi: 10.42 66/acc.2022.00052
  8. Wang F, Hu S, Ding Y, et al. Neutrophil-tolymphocyte ratio and 30-day mortality in patients with acute intracerebral hemorrhage. J Stroke Cerebrovas Dis. 2016;25(1):182-187. doi:10.1016/j.jstrokecerebrovasdis.20 15.09.013

Details

Primary Language

English

Subjects

Intensive Care

Journal Section

Research Article

Publication Date

January 5, 2026

Submission Date

September 10, 2025

Acceptance Date

November 10, 2025

Published in Issue

Year 2026 Volume: 9 Number: 1

APA
Tamdoğan, T., & Tamdoğan, İ. (2026). Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes. Journal of Health Sciences and Medicine, 9(1), 19-25. https://doi.org/10.32322/jhsm.1781699
AMA
1.Tamdoğan T, Tamdoğan İ. Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes. J Health Sci Med / JHSM. 2026;9(1):19-25. doi:10.32322/jhsm.1781699
Chicago
Tamdoğan, Tamer, and İlke Tamdoğan. 2026. “Prognostic Value of CAR, FIB-4, and Procalcitonin in Subdural Hematoma: Associations With Mortality and 90-Day Functional Outcomes Running Title: CAR, FIB-4, and Procalcitonin in SDH Outcomes”. Journal of Health Sciences and Medicine 9 (1): 19-25. https://doi.org/10.32322/jhsm.1781699.
EndNote
Tamdoğan T, Tamdoğan İ (January 1, 2026) Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes. Journal of Health Sciences and Medicine 9 1 19–25.
IEEE
[1]T. Tamdoğan and İ. Tamdoğan, “Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes”, J Health Sci Med / JHSM, vol. 9, no. 1, pp. 19–25, Jan. 2026, doi: 10.32322/jhsm.1781699.
ISNAD
Tamdoğan, Tamer - Tamdoğan, İlke. “Prognostic Value of CAR, FIB-4, and Procalcitonin in Subdural Hematoma: Associations With Mortality and 90-Day Functional Outcomes Running Title: CAR, FIB-4, and Procalcitonin in SDH Outcomes”. Journal of Health Sciences and Medicine 9/1 (January 1, 2026): 19-25. https://doi.org/10.32322/jhsm.1781699.
JAMA
1.Tamdoğan T, Tamdoğan İ. Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes. J Health Sci Med / JHSM. 2026;9:19–25.
MLA
Tamdoğan, Tamer, and İlke Tamdoğan. “Prognostic Value of CAR, FIB-4, and Procalcitonin in Subdural Hematoma: Associations With Mortality and 90-Day Functional Outcomes Running Title: CAR, FIB-4, and Procalcitonin in SDH Outcomes”. Journal of Health Sciences and Medicine, vol. 9, no. 1, Jan. 2026, pp. 19-25, doi:10.32322/jhsm.1781699.
Vancouver
1.Tamer Tamdoğan, İlke Tamdoğan. Prognostic value of CAR, FIB-4, and procalcitonin in subdural hematoma: associations with mortality and 90-day functional outcomes running title: CAR, FIB-4, and procalcitonin in SDH outcomes. J Health Sci Med / JHSM. 2026 Jan. 1;9(1):19-25. doi:10.32322/jhsm.1781699

Interuniversity Board (UAK) Equivalency: Article published in Ulakbim TR Index journal [10 POINTS], and Article published in other (excuding 1a, b, c) international indexed journal (1d) [5 POINTS].

The Directories (indexes) and Platforms we are included in are at the bottom of the page.

Note: Our journal is not WOS indexed and therefore is not classified as Q.

You can download Council of Higher Education (CoHG) [Yüksek Öğretim Kurumu (YÖK)] Criteria) decisions about predatory/questionable journals and the author's clarification text and journal charge policy from your browser. https://dergipark.org.tr/tr/journal/2316/file/4905/show







The indexes of the journal are ULAKBİM TR Dizin, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, etc.

       images?q=tbn:ANd9GcRB9r6zRLDl0Pz7om2DQkiTQXqDtuq64Eb1Qg&usqp=CAU

500px-WorldCat_logo.svg.png

atifdizini.png

logo_world_of_journals_no_margin.png

images?q=tbn%3AANd9GcTNpvUjQ4Ffc6uQBqMQrqYMR53c7bRqD9rohCINkko0Y1a_hPSn&usqp=CAU

doaj.png  

images?q=tbn:ANd9GcSpOQFsFv3RdX0lIQJC3SwkFIA-CceHin_ujli_JrqBy3A32A_Tx_oMoIZn96EcrpLwTQg&usqp=CAU

ici2.png

asos-index.png

drji.png





The platforms of the journal are Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons, etc.

COPE-logo-300x199.jpgimages?q=tbn:ANd9GcQR6_qdgvxMP9owgnYzJ1M6CS_XzR_d7orTjA&usqp=CAU

icmje_1_orig.png

cc.logo.large.png

ncbi.pngimages?q=tbn:ANd9GcRBcJw8ia8S9TI4Fun5vj3HPzEcEKIvF_jtnw&usqp=CAU

ORCID_logo.png

1*mvsP194Golg0Dmo2rjJ-oQ.jpeg


Our Journal using the DergiPark system indexed are;

Ulakbim TR Dizin,  Index Copernicus, ICI World of JournalsDirectory of Research Journals Indexing (DRJI), General Impact FactorASOS Index, OpenAIRE, MIAR,  EuroPub, WorldCat (OCLC)DOAJ,  Türkiye Citation Index, Türk Medline Index, InfoBase Index


Our Journal using the DergiPark system platforms are;

Google, Google Scholar, CrossRef (DOI), ResearchBib, ICJME, COPE, NCBI, ORCID, Creative Commons, Open Access, and etc.


Journal articles are evaluated as "Double-Blind Peer Review". 

Our journal has adopted the Open Access Policy and articles in JHSM are Open Access and fully comply with Open Access instructions. All articles in the system can be accessed and read without a journal user.  https//dergipark.org.tr/tr/pub/jhsm/page/9535

Journal charge policy   https://dergipark.org.tr/tr/pub/jhsm/page/10912

Our journal has been indexed in DOAJ as of May 18, 2020.

Our journal has been indexed in TR-Dizin as of March 12, 2021.


17873

Articles published in Journal of Health Sciences and Medicine have open access and are licensed under the Creative Commons CC BY-NC-ND 4.0 International License.